Michael Panzara
Direktor/Vorstandsmitglied bei ATHIRA PHARMA, INC.
Vermögen: - $ am 30.04.2024
Profil
Michael Panzara is an Independent Director at Athira Pharma, Inc. and the Chief Medical Officer at Neurvati Neurosciences, Inc. He was previously a Director at Wave Life Sciences UK Ltd.
from 2016 to 2022, the Chief Medical Officer-Neurology & Vice President at Biogen, Inc. from 2001 to 2009, and the Head-Multiple Sclerosis & Neurology at Genzyme Corp.
from 2009 to 2016.
He also served as the Chief Medical Officer & Head-Therapeutics at Wave Life Sciences Ltd.
from 2020 to 2022.
Panzara received his undergraduate degree from the University of Pennsylvania, his graduate degree from Harvard T.H.
Chan School of Public Health, and another undergraduate degree from Stanford University School of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ATHIRA PHARMA, INC.
-.--% | 24.05.2024 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Michael Panzara
| Unternehmen | Position | Beginn |
|---|---|---|
| ATHIRA PHARMA, INC. | Direktor/Vorstandsmitglied | 18.03.2022 |
| Neurvati Neurosciences, Inc. | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2022 |
Ehemalige bekannte Positionen von Michael Panzara
| Unternehmen | Position | Ende |
|---|---|---|
| WAVE LIFE SCIENCES LTD. | Technik-/Wissenschafts-/F&E-Leiter | 14.10.2022 |
Wave Life Sciences UK Ltd.
 Wave Life Sciences UK Ltd. Pharmaceuticals: MajorHealth Technology Part of Wave Life Sciences Ltd., Wave Life Sciences UK Ltd. is a pharmaceutical company founded in 2017. The company is based in Birmingham, UK and specializes in manufacturing pharmaceutical products. | Direktor/Vorstandsmitglied | 01.01.2022 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01.07.2016 |
| BIOGEN INC. | Corporate Officer/Principal | 01.09.2009 |
Ausbildung von Michael Panzara
| University of Pennsylvania | Undergraduate Degree |
| Stanford University School of Medicine | Undergraduate Degree |
| Harvard T.H. Chan School of Public Health | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| WAVE LIFE SCIENCES LTD. | Health Technology |
| BIOGEN INC. | Health Technology |
| ATHIRA PHARMA, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Wave Life Sciences UK Ltd.
Wave Life Sciences UK Ltd. Pharmaceuticals: MajorHealth Technology Part of Wave Life Sciences Ltd., Wave Life Sciences UK Ltd. is a pharmaceutical company founded in 2017. The company is based in Birmingham, UK and specializes in manufacturing pharmaceutical products. | Health Technology |
| Neurvati Neurosciences, Inc. |
